The Epstein-Barr virus (EBV) is a ubiquitous B-lymphotropic herpesvirus associated with several malignant
tumors, e.g.,
Burkitt's lymphoma and
Hodgkin's disease, and is able to efficiently immortalize primary B lymphocytes in vitro. The growth program of infected B cells is initiated and maintained by the viral transcription factor
EBV nuclear antigen 2 (EBNA2), which regulates viral and cellular genes, including the proto-oncogene c-myc. In our study, patterns of
protein expression in B cells with and without EBNA2 were analyzed by two-dimensional
polyacrylamide gel electrophoresis and mass spectrometry. For this purpose, we used a conditional immortalization system for EBV, a B cell line (EREB2-5) that expresses an
estrogen receptor-EBNA2 fusion
protein. In order to discriminate downstream targets of c-Myc from c-Myc-independent EBNA2 targets, we used an EREB2-5-derived cell line, P493-6, in which c-Myc is expressed under the control of a
tetracycline-regulated promoter. Of 20 identified EBNA2 target
proteins, 11 were c-Myc dependent and therefore most probably associated with proliferation, and one of these
proteins was a posttranslationally modified
protein, i.e., hypusinylated eIF5a. Finally, to estimate the relevance of EBNA2 targets during early
EBV infection, we analyzed the
proteomes of primary B cells before and after
infection with EBV. The
protein expression pattern induced upon
EBV infection was similar to that following EBNA2 activation. These findings underscore the value of EREB2-5 cells as an appropriate model system for the analysis of early events in the process of EBV-mediated B-cell immortalization.